PTC Therapeutics PTCT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $751.72M+19.5% | $629.17M+5.8% | $594.84M+264% | ||
| $47.01M+21.1% | $38.82M+18.8% | $32.68M+16.5% | $28.05M+2.1% | $27.49M-63.7% | ||
| $79.91M+7.2% | $74.55M+1.7% | $73.27M-0.4% | $73.6M-0.9% | $74.3M-0.4% | ||
| —— | —— | —— | —— | $691.65M+742% | ||
| $8.33M-5.9% | $8.86M-13.6% | $10.25M+39.9% | $7.33M— | —— | ||
| -$805.37M+10.1% | -$895.99M-42.6% | -$628.28M-64.8% | -$381.33M-1,410% | -$25.25M-157% | ||
| $328.09M-0.9% | $331.09M+501% | $55.06M+38.2% | $39.84M-85.9% | $282.36M+3.2% | ||
| —— | —— | —— | —— | $931.24M+403% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PTC Therapeutics generate?
- PTC Therapeutics (PTCT) generated $704.1M in operating cash flow over the trailing twelve months.
- What is PTC Therapeutics's free cash flow?
- After $8.3M of capital expenditures, PTC Therapeutics's free cash flow was $696.9M over the trailing twelve months, up 637.5% year over year.
- Where does PTC Therapeutics's cash flow data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
